CYT - Cyteir Therapeutics GAAP EPS of -$0.34 beats by $0.06 March, 16 2022 04:06 PM Cyteir Therapeutics Inc. Cyteir Therapeutics press release (NASDAQ:CYT): Q4 GAAP EPS of -$0.34 beats by $0.06. Q4 Cash and cash equivalents $189.72M For further details see: Cyteir Therapeutics GAAP EPS of -$0.34 beats by $0.06